Skip to content
Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • Optimal Care Pathway
    • For Patients
    • For Health Professionals
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • Optimal Care Pathway
    • For Patients
    • For Health Professionals
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » Research » 46th Annual Clinical Oncology Society of Australia (COSA) Meeting

46th Annual Clinical Oncology Society of Australia (COSA) Meeting

  • November 28, 2019

COSA held its 46th ASM in Adelaide 12 – 14 November 2019. There was an excellent attendance of multidisciplinary practitioners at the conference which was themed “Putting Precision and Personalisation into Practice”. COSA membership is diverse and the ASM celebrates this diversity with the depth of presentations by Clinicians, Researchers, Nurse, Pharmacists and Allied Health Professionals. There was a strong focus on Digital Technology to ensure comprehensive collection and utilization of data and also the impact of distance for cancer care. Another session was in the form of an MDT case discussion titled “A couple armed with an iPad” which covered gender issues, couples, sexuality, age and medicinal cannabis.

The Unicorn Foundation team attended the ASM. Over the three days there were sessions entitled “The Best of the Orals”, which saw the presented abstracts which had been submitted. Our CEO Simone, presented one of our current projects which is “Assessing the gaps in experience and knowledge of Australian Primary Health Care Professionals (GPs) in treating and caring for the increasing number of neuroendocrine tumour (NET) patients“. In this same session there was a presentation about – “Facilitating effective family carer engagement in cancer care – Development of education modules”.

On the final day the Plenary session was “Personalising cancer care at the population level: Beyond age and gender”. This presentation looked at cancer epidemiology across age spectrums (incidence, prevalence, burden and issues of disease, What about Race?, the emergence of youth cancer as a unique model of care and older cancer patients – the evolution of geriatric oncology and palliative care). Again this session was very thought provoking, taking into account the diversity of cancer patients and their needs. In the afternoon we had the privilege of an intimate Q&A and a performance by Kirk Pengilly (INXS band member) who talked about his cancer experience.

Meetings such as this ASM, are forums for updating and gaining knowledge of research and improvements in care. It also is a time to meet with International speakers and national colleagues to collaborate and share our work and plan for the future of cancer care.

Report by Meredith Cummins (UF Project Officer)

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

ENETS Conference 2023

March 27, 2023

Michael Doyle Live Wake Fundraiser

February 4, 2023

Optimal Care Pathway now available for NETs

January 31, 2023

World Cancer Day 2023

January 10, 2023
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousClinical Trials and Neuroendocrine Tumours
NextNeuroEndocrine Cancer Australia present 6 scientific abstracts at ENETs 2020Next

Related Posts

The Australian Cancer Plan

Shaping the future of cancer control together   We are pleased to send you this update on the Australian Cancer Plan, the first national 10-year

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Read full report

Peter MacCallum Cancer Centre – Recruiting NET health professionals for International Delphi survey

Recruiting NET health professionals for International Delphi survey Development of a neuroendocrine tumour (NET) nutrition-risk screening tool to identify patients requiring nutrition intervention and education

Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms

Read full report

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative